Overview of Newer Stent Devices for Aneurysm Treatmentsvin.org/files/Edgell_Over.pdf · The Surpass...
Transcript of Overview of Newer Stent Devices for Aneurysm Treatmentsvin.org/files/Edgell_Over.pdf · The Surpass...
![Page 1: Overview of Newer Stent Devices for Aneurysm Treatmentsvin.org/files/Edgell_Over.pdf · The Surpass IntraCranial Aneurysm EmbolizatioN System Pivotal Trial to Treat Large or Giant](https://reader034.fdocuments.us/reader034/viewer/2022042711/5f8014110555aa1f0e4bc285/html5/thumbnails/1.jpg)
Overview of Newer Stent Devices for Aneurysm Treatment
Randall C. Edgell, M.D. Associate Professor
Vascular and Interventional Neurology Saint Louis University
![Page 2: Overview of Newer Stent Devices for Aneurysm Treatmentsvin.org/files/Edgell_Over.pdf · The Surpass IntraCranial Aneurysm EmbolizatioN System Pivotal Trial to Treat Large or Giant](https://reader034.fdocuments.us/reader034/viewer/2022042711/5f8014110555aa1f0e4bc285/html5/thumbnails/2.jpg)
Disclosure
• Outcome adjudication for THERAPY, Penumbra
![Page 3: Overview of Newer Stent Devices for Aneurysm Treatmentsvin.org/files/Edgell_Over.pdf · The Surpass IntraCranial Aneurysm EmbolizatioN System Pivotal Trial to Treat Large or Giant](https://reader034.fdocuments.us/reader034/viewer/2022042711/5f8014110555aa1f0e4bc285/html5/thumbnails/3.jpg)
FDA Pathways
• Premarket Notification (510[K]): may allow device to go to market if “substantially equivalent” to previously marketed devices
• Pre-market Approval (PMA): Efficacy trial required – Investigational Device Exemption (IDE): allows use in
clinical trials
• Humanitarian Device Exemption (HDE): Only for rare diseases (<4,000 cases per year). Only requires demonstration of safety. Local IRB approval and monitoring required.
![Page 4: Overview of Newer Stent Devices for Aneurysm Treatmentsvin.org/files/Edgell_Over.pdf · The Surpass IntraCranial Aneurysm EmbolizatioN System Pivotal Trial to Treat Large or Giant](https://reader034.fdocuments.us/reader034/viewer/2022042711/5f8014110555aa1f0e4bc285/html5/thumbnails/4.jpg)
WARNING
• Most devises presented are investigational.
• Seeking HDE or PMA approval.
• Some slides/images graciously provided by industry
![Page 5: Overview of Newer Stent Devices for Aneurysm Treatmentsvin.org/files/Edgell_Over.pdf · The Surpass IntraCranial Aneurysm EmbolizatioN System Pivotal Trial to Treat Large or Giant](https://reader034.fdocuments.us/reader034/viewer/2022042711/5f8014110555aa1f0e4bc285/html5/thumbnails/5.jpg)
Flow Diverting Stents
![Page 6: Overview of Newer Stent Devices for Aneurysm Treatmentsvin.org/files/Edgell_Over.pdf · The Surpass IntraCranial Aneurysm EmbolizatioN System Pivotal Trial to Treat Large or Giant](https://reader034.fdocuments.us/reader034/viewer/2022042711/5f8014110555aa1f0e4bc285/html5/thumbnails/6.jpg)
PipelineTM Embolization Device(Covidien)
• 30-35% surface coverage at nominal diameter
• 48-strand braided mesh
• 75% cobalt chromium/25% platinum tungsten
• Scaffolding for endothelial repavement
• Branch vessels preserved
![Page 7: Overview of Newer Stent Devices for Aneurysm Treatmentsvin.org/files/Edgell_Over.pdf · The Surpass IntraCranial Aneurysm EmbolizatioN System Pivotal Trial to Treat Large or Giant](https://reader034.fdocuments.us/reader034/viewer/2022042711/5f8014110555aa1f0e4bc285/html5/thumbnails/7.jpg)
PipelineTM Embolization Device(Covidien)
![Page 8: Overview of Newer Stent Devices for Aneurysm Treatmentsvin.org/files/Edgell_Over.pdf · The Surpass IntraCranial Aneurysm EmbolizatioN System Pivotal Trial to Treat Large or Giant](https://reader034.fdocuments.us/reader034/viewer/2022042711/5f8014110555aa1f0e4bc285/html5/thumbnails/8.jpg)
PipelineTM Flex Embolization Device(Covidien)
Improved delivery systemt
New distal wire
Resheathable
No protective coil
![Page 9: Overview of Newer Stent Devices for Aneurysm Treatmentsvin.org/files/Edgell_Over.pdf · The Surpass IntraCranial Aneurysm EmbolizatioN System Pivotal Trial to Treat Large or Giant](https://reader034.fdocuments.us/reader034/viewer/2022042711/5f8014110555aa1f0e4bc285/html5/thumbnails/9.jpg)
SurpassTM Flow Diverter (Stryker)
• High pore density (72-wire & 96-wire braids)
• Long lengths (15mm to 50mm)
• 3mm, 4mm, 5mm diameters
![Page 10: Overview of Newer Stent Devices for Aneurysm Treatmentsvin.org/files/Edgell_Over.pdf · The Surpass IntraCranial Aneurysm EmbolizatioN System Pivotal Trial to Treat Large or Giant](https://reader034.fdocuments.us/reader034/viewer/2022042711/5f8014110555aa1f0e4bc285/html5/thumbnails/10.jpg)
Pusher Delivery Catheter Surpass Flow Diverter
SurpassTM Flow Diverter (Stryker)
![Page 11: Overview of Newer Stent Devices for Aneurysm Treatmentsvin.org/files/Edgell_Over.pdf · The Surpass IntraCranial Aneurysm EmbolizatioN System Pivotal Trial to Treat Large or Giant](https://reader034.fdocuments.us/reader034/viewer/2022042711/5f8014110555aa1f0e4bc285/html5/thumbnails/11.jpg)
Description Statistics
Number of Pts/Aneurysms Successfully Treated 161/186
Average Number of Devices/Aneurysm 1.05
Aneurysm Location Anterior (ICA) = 63.4% (118/186)
Anterior (Distal to Willis) = 22.0% (41/186)
Posterior Circulation = 14.5% (27/186)
Number of Pts Available for Safety/Clinical Follow-up (at 6Mo) 150 (Anterior = 123; Posterior = 27)
Primary Endpoint (any stroke and neurologic death) 12.0% (18/150)
Anterior Circulation 5.7% (7/123)
Posterior Circulation 14.8% (4/27)
Permanent Morbidity 6.0% (9/150)
Procedure-Related Mortality 2.7% (4/150)
Anterior Circulation 1.6% (2/123)
Posterior Circulation 7.4% (2/27)
Patients with Perforator Occlusion 0.7% (1/150)
Aneurysms Available for DSA Follow-up (at 6Mo) 84.9% (158/186)
Compete Occlusion 74.7% (118/158)
Anterior Circulation (ICA); Anterior Circulation (Distal to Willis) 78.6% (77/98); 65.8% (25/38)
Posterior Circulation 72.7% (16/22)
Near Complete Occlusion (>95%) or Complete Occlusion 80.4% (127/158)
Surpass Flow Diverter in the Treatment of Intracranial Aneurysms: A Prospective Multicenter Study. A.K. Wakhloo, et al. for the Surpass Study Group (AJNR Am. J. Neuroradiol. 2014 : ajnr.A4078v1-0.)
![Page 12: Overview of Newer Stent Devices for Aneurysm Treatmentsvin.org/files/Edgell_Over.pdf · The Surpass IntraCranial Aneurysm EmbolizatioN System Pivotal Trial to Treat Large or Giant](https://reader034.fdocuments.us/reader034/viewer/2022042711/5f8014110555aa1f0e4bc285/html5/thumbnails/12.jpg)
SurpassTM Flow Diverter (Stryker)
De Vries J et al. Stroke. 2013;44:1567-1577
![Page 13: Overview of Newer Stent Devices for Aneurysm Treatmentsvin.org/files/Edgell_Over.pdf · The Surpass IntraCranial Aneurysm EmbolizatioN System Pivotal Trial to Treat Large or Giant](https://reader034.fdocuments.us/reader034/viewer/2022042711/5f8014110555aa1f0e4bc285/html5/thumbnails/13.jpg)
SCENT Trial
The Surpass IntraCranial Aneurysm EmbolizatioN System Pivotal Trial to Treat Large or Giant Wide Neck Aneurysms
• Multi-center (23 US sites)
• Single-arm
• Prospective
• Non-randomized
• PMA trial
For patients that have a single targeted intracranial aneurysm that:
• Is located in the internal carotid artery (ICA) distribution up to the terminus
• Has a neck >4 mm or no discernible neck and an aneurysm size >10 mm (including saccular, fusiform and dissecting configuration)
![Page 14: Overview of Newer Stent Devices for Aneurysm Treatmentsvin.org/files/Edgell_Over.pdf · The Surpass IntraCranial Aneurysm EmbolizatioN System Pivotal Trial to Treat Large or Giant](https://reader034.fdocuments.us/reader034/viewer/2022042711/5f8014110555aa1f0e4bc285/html5/thumbnails/14.jpg)
Aneurysm Scaffold Devices
![Page 15: Overview of Newer Stent Devices for Aneurysm Treatmentsvin.org/files/Edgell_Over.pdf · The Surpass IntraCranial Aneurysm EmbolizatioN System Pivotal Trial to Treat Large or Giant](https://reader034.fdocuments.us/reader034/viewer/2022042711/5f8014110555aa1f0e4bc285/html5/thumbnails/15.jpg)
Current Aneurysm Stents Embody 12 Year Old HDE Technology
Stroke. 2009; 40: e305-e312
![Page 16: Overview of Newer Stent Devices for Aneurysm Treatmentsvin.org/files/Edgell_Over.pdf · The Surpass IntraCranial Aneurysm EmbolizatioN System Pivotal Trial to Treat Large or Giant](https://reader034.fdocuments.us/reader034/viewer/2022042711/5f8014110555aa1f0e4bc285/html5/thumbnails/16.jpg)
Common Goals
• Improved wall apposition
• Increased surface area coverage
• Resheathable
• Deliverable through standard coiling catheters
• PMA not HDE approval pathway
![Page 17: Overview of Newer Stent Devices for Aneurysm Treatmentsvin.org/files/Edgell_Over.pdf · The Surpass IntraCranial Aneurysm EmbolizatioN System Pivotal Trial to Treat Large or Giant](https://reader034.fdocuments.us/reader034/viewer/2022042711/5f8014110555aa1f0e4bc285/html5/thumbnails/17.jpg)
LibertyTM Stent System (Penumbra)
![Page 18: Overview of Newer Stent Devices for Aneurysm Treatmentsvin.org/files/Edgell_Over.pdf · The Surpass IntraCranial Aneurysm EmbolizatioN System Pivotal Trial to Treat Large or Giant](https://reader034.fdocuments.us/reader034/viewer/2022042711/5f8014110555aa1f0e4bc285/html5/thumbnails/18.jpg)
LibertyTM Stent System (Penumbra)
![Page 19: Overview of Newer Stent Devices for Aneurysm Treatmentsvin.org/files/Edgell_Over.pdf · The Surpass IntraCranial Aneurysm EmbolizatioN System Pivotal Trial to Treat Large or Giant](https://reader034.fdocuments.us/reader034/viewer/2022042711/5f8014110555aa1f0e4bc285/html5/thumbnails/19.jpg)
Dense Mesh Neck Coverage
Stent Approximate Coverage
Neuroform, Enterprise 6%
Liberty 15%
Pipeline, Silk 30%
![Page 20: Overview of Newer Stent Devices for Aneurysm Treatmentsvin.org/files/Edgell_Over.pdf · The Surpass IntraCranial Aneurysm EmbolizatioN System Pivotal Trial to Treat Large or Giant](https://reader034.fdocuments.us/reader034/viewer/2022042711/5f8014110555aa1f0e4bc285/html5/thumbnails/20.jpg)
Liberty Clinical Trial Pathway
• Premarket Approval Pathway
• Single Arm Trial, 120 patients
• ICA Aneurysms only (per FDA guidance)
• Primary Endpoint: Complete occlusion (Raymond Scale 1) at 6 months without rupture, retreatment or parent artery compromise.
![Page 21: Overview of Newer Stent Devices for Aneurysm Treatmentsvin.org/files/Edgell_Over.pdf · The Surpass IntraCranial Aneurysm EmbolizatioN System Pivotal Trial to Treat Large or Giant](https://reader034.fdocuments.us/reader034/viewer/2022042711/5f8014110555aa1f0e4bc285/html5/thumbnails/21.jpg)
LVIS® Device Key Features
(Microvention)
• Braided design
• Increased visibility
• Deliverable through Scepter Balloon
• LVIS®
• LVIS Jr. ®
• PMA trial ongoing
![Page 22: Overview of Newer Stent Devices for Aneurysm Treatmentsvin.org/files/Edgell_Over.pdf · The Surpass IntraCranial Aneurysm EmbolizatioN System Pivotal Trial to Treat Large or Giant](https://reader034.fdocuments.us/reader034/viewer/2022042711/5f8014110555aa1f0e4bc285/html5/thumbnails/22.jpg)
LVIS vs. LVIS Jr. Device Comparison
Attribute LVIS LVIS Jr. No. of wires 16 12
Implant Material Nitinol Nitinol RO Material Tantalum Tantalum
Headway MC Compatibility 21 17
No. of Flared Ends 4 3 No. of Helical RO Wires 2 3
Implant Wire OD .0023-.0025“ (58 – 64 um)
0.0023 -.0025” (58 – 64 um)
Retrievability up to ~80% ~75% Foreshortening 30% max 22% max Metal Surface Area (%) 22% max 18% max
Cell Size (mm) ~1.0mm ~1.5mm Pusher Material Nitinol Stainless
Steel
LVIS Jr.
LVIS
![Page 23: Overview of Newer Stent Devices for Aneurysm Treatmentsvin.org/files/Edgell_Over.pdf · The Surpass IntraCranial Aneurysm EmbolizatioN System Pivotal Trial to Treat Large or Giant](https://reader034.fdocuments.us/reader034/viewer/2022042711/5f8014110555aa1f0e4bc285/html5/thumbnails/23.jpg)
Competitive Neck Coverage Analysis
20%
17%
11%10%
0%
5%
10%
15%
20%
25%
LVIS® Jr LVIS® NeuroForm™ Enterprise™
Average % Metal Coverage in vessels from 3.0 to 4.0 mm
* * *
![Page 24: Overview of Newer Stent Devices for Aneurysm Treatmentsvin.org/files/Edgell_Over.pdf · The Surpass IntraCranial Aneurysm EmbolizatioN System Pivotal Trial to Treat Large or Giant](https://reader034.fdocuments.us/reader034/viewer/2022042711/5f8014110555aa1f0e4bc285/html5/thumbnails/24.jpg)
Visibility Comparison
NeuroForm™
Enterprise™
LVIS® Distal
4 markers
Proximal
2 grouped markers
Body
2 strands
LVIS® Jr Distal
3 markers
Proximal
3 markers
Body
3 strands
Laser-Cut Stents: Visible only at ends
The LVIS® & LVIS® Jr. Devices:
Visible throughout the entire body, not just the ends
![Page 25: Overview of Newer Stent Devices for Aneurysm Treatmentsvin.org/files/Edgell_Over.pdf · The Surpass IntraCranial Aneurysm EmbolizatioN System Pivotal Trial to Treat Large or Giant](https://reader034.fdocuments.us/reader034/viewer/2022042711/5f8014110555aa1f0e4bc285/html5/thumbnails/25.jpg)
LVIS® Jr. Delivery Through Scepter Balloons
1 - Balloon assisted embolization 2 - After balloon deflation, if a coil prolapses
into the parent vessel
3 – Deliver LVIS® Jr. device through the
Scepter C® or Scepter XC® Balloon
4 – Deploy the stent 5 – The stent is placed in the parent vessel, trapping
the coil in the aneurysm
![Page 26: Overview of Newer Stent Devices for Aneurysm Treatmentsvin.org/files/Edgell_Over.pdf · The Surpass IntraCranial Aneurysm EmbolizatioN System Pivotal Trial to Treat Large or Giant](https://reader034.fdocuments.us/reader034/viewer/2022042711/5f8014110555aa1f0e4bc285/html5/thumbnails/26.jpg)
PulseRider (Pulsar Vascular/Codman Neuro)
![Page 27: Overview of Newer Stent Devices for Aneurysm Treatmentsvin.org/files/Edgell_Over.pdf · The Surpass IntraCranial Aneurysm EmbolizatioN System Pivotal Trial to Treat Large or Giant](https://reader034.fdocuments.us/reader034/viewer/2022042711/5f8014110555aa1f0e4bc285/html5/thumbnails/27.jpg)
PulseRider (Pulsar Vascular/Codman Neuro)
• In conjunction with detachable coils
• Self-expanding, Nitinol, neck scaffold
• Fully retrievable
• IDE approval, study ongoing
• Seeking HDE approval for treatment of basilar tip aneurysms
![Page 28: Overview of Newer Stent Devices for Aneurysm Treatmentsvin.org/files/Edgell_Over.pdf · The Surpass IntraCranial Aneurysm EmbolizatioN System Pivotal Trial to Treat Large or Giant](https://reader034.fdocuments.us/reader034/viewer/2022042711/5f8014110555aa1f0e4bc285/html5/thumbnails/28.jpg)
Intra-aneurysmal Flow Diversion
![Page 29: Overview of Newer Stent Devices for Aneurysm Treatmentsvin.org/files/Edgell_Over.pdf · The Surpass IntraCranial Aneurysm EmbolizatioN System Pivotal Trial to Treat Large or Giant](https://reader034.fdocuments.us/reader034/viewer/2022042711/5f8014110555aa1f0e4bc285/html5/thumbnails/29.jpg)
Anatomy of Luna™ AES Implant (Covidien)
Double layer, Nitinol Wire 0.001”
Mesh basket
Proximal & distal radiopaque markers (Platinum)
9 Sizes: 4.5 – 8.5 mm
![Page 30: Overview of Newer Stent Devices for Aneurysm Treatmentsvin.org/files/Edgell_Over.pdf · The Surpass IntraCranial Aneurysm EmbolizatioN System Pivotal Trial to Treat Large or Giant](https://reader034.fdocuments.us/reader034/viewer/2022042711/5f8014110555aa1f0e4bc285/html5/thumbnails/30.jpg)
Woven Endobridge (WEB) (Sequent Medical)
• Retrievable
• Nitinol
![Page 31: Overview of Newer Stent Devices for Aneurysm Treatmentsvin.org/files/Edgell_Over.pdf · The Surpass IntraCranial Aneurysm EmbolizatioN System Pivotal Trial to Treat Large or Giant](https://reader034.fdocuments.us/reader034/viewer/2022042711/5f8014110555aa1f0e4bc285/html5/thumbnails/31.jpg)